Details of the Drug

General Information of Drug (ID: DM2XVCE)

• Drug Name: DPX-0907

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 1	[1]

• Cross-matching ID: TTD ID: D0RW5O

References

• [1] ClinicalTrials.gov (NCT01095848) A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer. U.S. National Institutes of Health.